Adenosine A1 and A2 receptors mediate tone-dependent responses in feline pulmonary vascular bed

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Cheng, David Y ^b   Dewitt, Bracken J ^b   Suzuki, Fumio ^b   Neely, Constance F ^b   Kadowitz, Philip J ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

high energy nucleotide; purine nucleoside; vasoconstrictor prostaglandins

Indexed keywords

6 N CYCLOPENTYLADENOSINE; 8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ANGIOTENSIN; BRADYKININ; DIETHYLAMINE; ISOPRENALINE; LEMAKALIM; MECLOFENAMIC ACID; METHYLENE BLUE; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; NITRIC OXIDE; NORADRENALIN; PROSTANOID; SEROTONIN; 1,3-DIPROPYL-8-(3-NORADAMANTYL)XANTHINE; ADAMANTANE; ADENOSINE RECEPTOR; ARGININE; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; N(W) NITROARGININE BENZYL ESTER; N(W)-NITROARGININE BENZYL ESTER; PROSTAGLANDIN SYNTHASE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CAT; CONTROLLED STUDY; FEMALE; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; LUNG CIRCULATION; METABOLISM; MUSCLE TONE; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ADAMANTANE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ARGININE; CATS; FEMALE; MALE; METHYLENE BLUE; MORPHOLINES; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PULMONARY CIRCULATION; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0029689702     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.1.h200     Document Type: Article

References (34)

1. 2 receptor mechanism. J. Appl. Physiol. 74: 982-988, 1993.
2. Arch, J. R. S., and E. A. Newsholme. The control of the metabolism and the hormonal role of adenosine. In: Essays in Biochemistry, edited by P. W. Campbell and W. H. Aldrich. New York: Academic, 1978, vol. 16, p 18-123.
3. 2 receptor subtype selectivity of adenosine receptor agonists in vivo. J. Pharmacol. Exp. Ther. 268: 1166-1173, 1994.
4. Bennet, D. W., and A. N. Drury. Further observations relating to the physiological activity of adenine compounds. J. Physiol. Lond. 72: 288-320, 1931.
5. 2/prostaglandin endoperoxide-receptor activation. Circ. Res. 65: 1516-1525, 1989.
6. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29: 331-346, 1986.
7. Burnstock, G. A basis for distinguishing two types of purinergic receptors. In: Cell Membrane Receptors for Drug and Hormones: A Multidisciplinary Approach, edited by R. W. Straub and L. Bolis. New York: Raven, 1978, p. 107-118.
8. Daly, J. W. Adenosine receptors: targets for future drugs. J. Med. Chem. 25: 197-207, 1982.
9. Drury, A. N., and A. Szent-Gyorgi. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol. Lond. 68: 213-237, 1929.
10. Emmelin, N., and W. Feldberg. Systemic effects of adenosine triphosphate. Br. J. Pharmacol. 3: 273-284, 1948.
11. Gaddum, J. H., and P. Holtz. The localization of the action of drugs on the pulmonary vessels of dogs and cats. J. Physiol. Lond. 77: 139-158, 1933.
12. Hauge, A., P. K. M. Lunde, and B. A. Waaler. Vasoconstriction in isolated blood-perfused rabbit lungs and its inhibition by cresols. Acta Physiol. Scand. 66: 226-240, 1966.
13. Joad, J. P. Characterization of the human peripheral lung adenosine receptor. Am. J. Respir. Cell Mol. Biol. 2: 193-198, 1990.
14. 2-purinoceptor subtypes-an update. Arch. Int. Pharmacodyn. Ther. 303: 30-50, 1990.
15. 6-substituted adenosines. J. Med. Chem. 16: 1381-1388, 1973.
16. 1-receptor antagonist, on its pharmacological actions. Jpn. J. Pharmacol. 63: 513-519, 1993.
17. 2-purinoceptor subtypes in rat pulmonary vessels. J. Pharmacol. Exp. Ther. 251: 1204-1210, 1989.
18. McCormack, D. B., B. Clarke, and P. J. Barnes. Characterization of adenosine receptors in human pulmonary arteries. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H41-H46, 1989.
19. McMahon, T. J., and P. J. Kadowitz. Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the cat. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L575-L584, 1992.
20. Mentzer, R. M., R. Rubio, and R. M. Berne. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am. J. Physiol. 229: 1625-1631, 1975.
21. 1-receptor antagonist, via pertussis toxin insensitive mechanism. J. Pharmacol. Exp. Ther. 266: 200-266, 1993.
22. 1-selective adenosine agonists. J. Med. Chem. 28: 1383-1384, 1985.
23. Morgan, J. M., D. G. McCormack, M. J. D. Griffiths, C. J. Morgan, P. J. Barnes, and T. W. Evans. Adenosine as a vasodilator in pulmonary hypertension. Circulation 84: 1145-1149, 1991.
24. Needleman, P., M. S. Minkes, and J. R. Douglas. Stimulation of prostaglandin biosynthesis by adenine nucleotides. Circ. Res. 34: 455-460, 1974.
25. Neely, C. F., D. M. Haile, B. E. Cahill, and P. J. Kadowitz. Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms. J. Pharmacol. Exp. Ther. 258: 753-761, 1991.
26. Neely, C. F., P. J. Kadowitz, H. Lippton, M. Neiman, and A. L. Hyman. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5′-triphosphate in the feline pulmonary vascular bed. J. Pharmacol. Exp. Ther. 250: 170-176, 1989.
27. Neely, C. F., and J. Nguyen. Acute increase in pulmonary vascular tone alters 5′-nucleotidase activity (Abstract). FASEB J. 77: 148, 1994.
28. 2 receptor antagonist. Eur. J. Pharmacol. 267: 335-341, 1994.
29. Reeves, J. T., P. Jokl, J. Merida, and J. E. Leathers. Pulmonary vascular obstruction following administration of high-energy nucleotides. J. Appl. Physiol. 22: 475-479, 1967.
30. Rudolph, A. M., M. D. Kurland, A. M. Auld, and M. H. Paul. Effects of vasodilator drugs on normal and serotonin-constricted pulmonary vessels of the dog. Am. J. Physiol. 197: 617-623, 1959.
31. Snedecor, G. W., and W. G. Cochran. Statistical Methods (7th ed.). Ames: Iowa State University Press, 1980.
32. 1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects agonist acute renal failure. J. Med. Chem. 35: 3066-3075, 1992.
33. Van Calker, D., M. Muller, and B. Hamprecht. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurosci. 33: 999-1005, 1979.
34. Williams, M., A. Braunwalder, and T. J. Erickson. Evaluation of the binding of the A-1 selective adenosine radioligand cyclopentyladenosine (CPA) to rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 332: 179-183, 1986.